CSM
ASXC

CAMG Solamere Management’s Asensus Surgical, Inc. ASXC Stock Holding History

CAMG Solamere Management’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$31K Buy
+16,693
New +$37.5K 0.03% 83

Other funds holding ASXC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

CAMG Solamere Management's ASXC Position: Q3 2021 in Review

CAMG Solamere Management opened a new position in Asensus Surgical, Inc. (ASXC) in Q3 2021: 16,693 shares worth $31K. The stake represents 0.03% of the portfolio and ranks #83 among its holdings.

111 funds tracked by Wall St. Rank hold ASXC as of Q3 2021.

  • CAMG Solamere Management held 16,693 shares of Asensus Surgical, Inc. worth $31K as of Q3 2021.
  • Asensus Surgical, Inc. was a new CAMG Solamere Management position in Q3 2021.
  • Asensus Surgical, Inc. made up 0.03% of CAMG Solamere Management's portfolio in Q3 2021, its #83 holding.
  • 111 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2021.

Based on CAMG Solamere Management's 13F filing for Q3 2021, filed 12 Nov 2021.